European CHMP Issues Positive Opinion for Cariprazine for the Treatment of Schizophrenia

Gedeon Richter Plc. announces that the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a positive opinion on the company’s application for cariprazine, a novel antipsychotic for the treatment of schizophrenia in adult patients.